DEA schedule
Is topiramate a controlled substance?
Federal schedule for topiramate from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Topiramate is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and topiramate is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted topiramate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 303 prescription listings from 50 labelers, none with a DEA schedule |
| DEA controlled substances list | topiramate is not on the list |
Topiramate NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 52652-9001 | Eprontia | solution | 25 mg/mL | Azurity Pharmaceuticals, Inc. | None |
| 0245-1074 | QUDEXY XR | capsule, extended release | 100 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 0245-1075 | QUDEXY XR | capsule, extended release | 150 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 0245-1073 | QUDEXY XR | capsule, extended release | 200 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 0245-1071 | QUDEXY XR | capsule, extended release | 25 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 0245-1072 | QUDEXY XR | capsule, extended release | 50 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 50458-647 | Topamax | capsule, coated pellets | 15 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-645 | Topamax | capsule, coated pellets | 25 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-641 | Topamax | tablet, coated | 100 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-642 | Topamax | tablet, coated | 200 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-639 | Topamax | tablet, coated | 25 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 50458-640 | Topamax | tablet, coated | 50 mg/1 | Janssen Pharmaceuticals, Inc. | None |
| 17772-103 | Trokendi XR | capsule, extended release | 100 mg/1 | Supernus Pharmaceuticals, Inc. | None |
| 17772-104 | Trokendi XR | capsule, extended release | 200 mg/1 | Supernus Pharmaceuticals, Inc. | None |
| 17772-101 | Trokendi XR | capsule, extended release | 25 mg/1 | Supernus Pharmaceuticals, Inc. | None |
| 17772-102 | Trokendi XR | capsule, extended release | 50 mg/1 | Supernus Pharmaceuticals, Inc. | None |
| 24979-210 | Topiramate | capsule | 15 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 59651-452 | TOPIRAMATE | capsule | 15 mg/1 | Aurobindo Pharma Limited | None |
| 67877-868 | Topiramate | capsule | 15 mg/1 | Ascend Laboratories, LLC | None |
| 72888-228 | Topiramate | capsule | 15 mg/1 | Advagen Pharma Ltd | None |
| 24979-211 | Topiramate | capsule | 25 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 59651-453 | TOPIRAMATE | capsule | 25 mg/1 | Aurobindo Pharma Limited | None |
| 67877-869 | Topiramate | capsule | 25 mg/1 | Ascend Laboratories, LLC | None |
| 72888-229 | Topiramate | capsule | 25 mg/1 | Advagen Pharma Ltd | None |
| 72888-230 | Topiramate | capsule | 50 mg/1 | Advagen Pharma Ltd | None |
| 65841-651 | topiramate | capsule, coated pellets | 15 mg/1 | Zydus Lifesciences Limited | None |
| 68382-004 | topiramate | capsule, coated pellets | 15 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 68462-218 | Topiramate | capsule, coated pellets | 15 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 65841-652 | topiramate | capsule, coated pellets | 25 mg/1 | Zydus Lifesciences Limited | None |
| 68382-005 | topiramate | capsule, coated pellets | 25 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 68462-219 | Topiramate | capsule, coated pellets | 25 mg/1 | Glenmark Pharmaceuticals Inc., USA | None |
| 70518-4247 | topiramate | capsule, coated pellets | 25 mg/1 | REMEDYREPACK INC. | None |
| 65841-846 | topiramate | capsule, coated pellets | 50 mg/1 | Zydus Lifesciences Limited | None |
| 68382-498 | topiramate | capsule, coated pellets | 50 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 0480-2358 | Topiramate | capsule, extended release | 100 mg/1 | Teva Pharmaceuticals, Inc. | None |
| 0832-1074 | Topiramate | capsule, extended release | 100 mg/1 | Upsher-Smith Laboratories, LLC | None |
| 10370-367 | Topiramate | capsule, extended release | 100 mg/1 | Par Health USA, LLC | None |
| 27241-229 | Topiramate | capsule, extended release | 100 mg/1 | Ajanta Pharma USA Inc. | None |
| 27241-298 | Topiramate | capsule, extended release | 100 mg/1 | Ajanta Pharma USA Inc. | None |
| 27808-327 | Topiramate | capsule, extended release | 100 mg/1 | Cranbury Pharmaceuticals, LLC | None |
Showing 40 of 303 listings.
Questions
Is topiramate a controlled substance?
No. Topiramate is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and topiramate is not on the DEA controlled substances list.
Is topiramate a narcotic?
No. Topiramate is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Topiramate
- What is Topiramate used for?FDA label uses
- Generic for Qudexy XRFDA Orange Book
- Generic for Trokendi XRFDA Orange Book
- Generic for TopamaxFDA Orange Book
- Generic for Topamax SprinkleFDA Orange Book
- Generic for EprontiaFDA Orange Book
- What is Topamax used for?FDA label uses
- Is Topamax a controlled substance?Federal schedule
- What is Trokendi XR used for?FDA label uses
- Is Trokendi XR a controlled substance?Federal schedule
- NDC 0245-1071Topiramate NDC record
- NDC 0245-1072Topiramate NDC record
- NDC 0245-1073Topiramate NDC record